177Lu-DOTA-rosopatamab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-DOTA-rosopatamab, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only [Phase 3]